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Candida albicans, a causative agent of opportunistic fun-
gal infections in immunocompromised patients, uses 
ten secreted aspartic proteases (SAPs) to deregulate the 
homeostasis of the host organism on many levels. One 
of these deregulation mechanisms involves a SAP-de-
pendent disturbance of the control over proteolytic en-
zymes of the host by a system of dedicated proteinase 
inhibitors, with one important example being the neu-
trophil elastase and alpha1-proteinase inhibitor (A1PI). In 
this study, we found that soluble SAPs 1-4 and the cell 
membrane-anchored SAP9 efficiently cleaved A1PI, with 
the major cleavage points located at the C-terminal part 
of A1PI in a close vicinity to the reactive-site loop that 
plays a critical role in the inhibition mechanism. Elastase 
is released by neutrophils to the environment during 
fungal infection through two major processes, a de-
granulation or formation of neutrophil extracellular traps 
(NET). Both, free and NET-embedded elastase forms, 
were found to be controlled by A1PI. A local acidosis, re-
sulting from the neutrophil activity at the infection sites, 
favors A1PI degradation by SAPs. The deregulation of 
NET-connected elastase affected a NET-dependent dam-
age of epithelial and endothelial cells, resulting in the 
increased susceptibility of these host cells to candidal 
colonization. Moreover, the SAP-catalyzed cleavage of 
A1PI was found to decrease its binding affinity to a pro-
inflammatory cytokine, interleukin-8. The findings pre-
sented here suggest a novel strategy used by C. albicans 
for the colonization of host tissues and overcoming the 
host defense.
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INTRODUCTION
Candida albicans is an opportunistic pathogen, harm-
lessly colonizing the human organism and detected in up 
to 70% of healthy individuals. However, weakening the 
host immune system and the frequent use of antibiotics 
and steroids increase a risk of fungal infections (Bakare 
et al., 2003). In severe conditions, the superficial infec-
tions may further develop into life-threatening dissemi-
nated candidiasis with a high (30–50%) mortality rate 
(Santos & Braga-Silva, 2013). To invade host mucosal 
surfaces, C. albicans uses many virulence factors that en-
able the fungal cells to survive in a diverse physiological 
niches such as oropharynx or urogenital or gastrointesti-
nal tracts (Calderone & Fonzi, 2001; Mech et al., 2013). 
Among them, a crucial role is played by a family of se-
creted aspartic proteases (SAPs) whose expression differs 
between unicellular (yeast-like) and filamentous morpho-
logical forms of C. albicans (Naglik et al., 2003). A major-
ity of SAPs are released to the surrounding environment 
(SAP1-SAP8) but SAP9 and SAP10 are attached to the 
cell wall/membrane through a glycosylphosphatidylino-
sitol (GPI) anchor (Hube & Naglik, 2001). These pro-
teases exhibit broad substrate specificities, promoting in-
fection development by the degradation of host proteins 
that function in tissue barriers and in immune defense 
(Pietrella et al., 2010; Rapala-Kozik et al., 2015; Kozik et 
al., 2015).
Neutrophils are principal mediators of innate immu-
nity against microbial invaders. Apart from the phago-
cytosis and extracellular degranulation, they are able to 
combat microbes by formation of neutrophil extracel-
lular traps (NETs). These web-like structures are built 
of a decondensed chromatin and numerous proteins, 
mainly originating from neutrophil granules, with anti-
microbial properties (Urban et al., 2009). However, the 
NET release poses a threat to the tissue, associated with 
the proteolytic activity of neutrophil proteases (such 
as elastase and proteinase 3) and the oxidative proper-
ties of myeloperoxidase, the enzymes that are important 
structural elements of NETs. Elastase (NE) plays pivotal 
roles in the pathogenesis of pulmonary fibrosis and in 
the development and progression of acute respiratory 
distress syndrome (Takemasa et al., 2012; Tagami et al., 
2014). Initially, NE is stored in the azurophilic granules 
of neutrophils, but during NET formation it processes 
core histones to promote chromatin decondensation 
and contributes to NET-dependent tissue damage after 
NET release into the surrounding environment (Papay-
annopoulos et al., 2011). Therefore, processes such as 
the neutrophil migration, initiation of the trap forma-
tion and elastase activity must be strictly controlled. 
Regulation may occur by means of α1-protease inhibi-
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tor (A1PI). This member of the serpin (serine protease 
inhibitor) family, synthesized mainly by hepatocytes, is 
the main NE inhibitor that circulates in the bloodstream 
from which it diffuses into the lower respiratory tract, 
providing > 90% anti-elastase protection there (Greene 
et al., 2003). It is known that in addition to its inhibi-
tory properties, A1PI also has a regulatory capacity in 
the inflammatory processes, weakening both neutrophil 
chemotaxis due to IL-8 binding (Bergin et al., 2010) and 
the production of free radicals, probably due to some 
ROS-scavenging properties (Taggart et al., 2000).
Bacteria that cause pulmonary infections, such as Pseu-
domonas aeruginosa, Haemophilus influenzae and Staphylococcus 
aureus, express enzymes capable of inactivating A1PI, 
thus contributing to an impaired balance between NE 
and A1PI within the airways that can lead to tissue de-
struction and progression of the disease (Suter & Cheval-
lier, 1991). It was also suggested that the common fungal 
pathogen — C. albicans yeast — can affect the integrity 
and function of A1PI (Kaminishi, 1999). Therefore, aim 
of the present study was to analyze the cleavage of A1PI 
by SAPs and the effects of this proteolytic processing 
on the NET-embedded NE activity and NET-dependent 
damage of epithelial and endothelial cells, with a possible 
further influence on the propagation of fungal infection.
MATERIALS AND METHODS
Cell culturing. Human microvascular endothelial 
cells (HMEC-1) and human epithelial carcinoma cell 
line A431 were obtained from ATCC. HMEC-1 were 
cultured in MCDB 131 medium (Sigma, St. Louis, MO, 
USA) and A431 cells in DMEM medium (Thermo Scien-
tific, HyClone, Logan, USA). Media were supplemented 
with 10% fetal bovine serum (FBS), 100 units/ml peni-
cillin–streptomycin and 2 mM glutamine, and MCDB 
131 medium was additionally supplemented with 1 µg/
ml hydrocortisone and 10 ng/ml EGF. The cells were 
cultured in 5% CO2 atmosphere at 37°C.
Yeast culturing. C. albicans strain ATCC 10231 was 
grown under conditions that favored either yeast-like 
or hyphal morphology. Yeast-like forms were cultured 
at 30ºC in YPD medium (Serva, Heidelberg, Germany) 
buffered with 50 mM sodium-phosphate pH 6.5 and 
containing 0.2% yeast extract, 0.2% peptone and 2% 
glucose. In order to induce hyphae formation, C. albi-
cans was grown in RPMI medium (Sigma) at 37°C. Af-
ter 24 h, the yeast cells were harvested by centrifugation 
(3 000 × g, 10 min) and SAP-containing supernatants were 
ten-fold concentrated using an Amicon ultrafiltration 
chamber (Danvers, MA) equipped with the ultrafiltration 
membrane with 10-kDa exclusion limit.
Isolation of neutrophils from human peripheral 
blood. Human neutrophils were isolated according to a 
previously described method (Rapala-Kozik et al., 2015) 
using EDTA-treated whole-blood samples collected 
from healthy donors. Neutrophil-containing fractions 
were separated by Pancoll gradient (PAN-Biotech, Aid-
enbach, Germany) and treated with 1% solution of poly-
vinyl alcohol (Sigma) in PBS. Contaminating erythrocytes 
were removed by hypotonic lysis, and neutrophils were 
resuspended in RPMI 1640 medium (phenol red-free). 
This preparation method yields a > 95% pure population 
of neutrophils.
NET release and isolation. Neutrophils (1 × 106 
cells in 800 μl RPMI) were seeded for 30 min at 37°C 
and 5% CO2, on a 12-well microplate (Greiner Bio-
One, Germany), previously coated with 0.01% poly-L-ly-
sine. Cells were then stimulated to produce NETs with 
50 nM phorbol 12-myristate 13-acetate (PMA) (Sigma) 
for 3 hours at 37°C and 5% CO2. After gentle triple 
washing of each well with 1 ml of PBS, NETs were 
treated with 400 μl of Micrococcal nuclease (MNase, 
1 U/ml) (Roche, Penzberg, Germany) for 20 min at 
37°C. The reaction was stopped with EDTA. The su-
pernatant was collected and centrifuged for 5 min at 
300 × g at 4°C to remove the cell debris. The NET-rich 
supernatants were then analyzed for their DNA frag-
mentation using agarose gel electrophoresis. For protein 
determination in the samples, Micro-BCA protein assay 
reagent kit (Pierce, Germany) was used and DNA con-
tent was quantified using staining with SytoxGreen (In-
vitrogen Life Technologies, Germany) and fluorescence 
measurement (465/525nm) using a Biotek Synergy H1 
microplate reader.
Degradation of A1PI in SAP-containing super-
natants. A1PI (1 µg/30 µl) (Preparatis, Poland) was 
incubated with cell-free supernatants containing 5 µg/
ml of secreted proteins at pH in the range of 4–7 (50 
mM citrate pH 4-6 or 50 mM phosphate buffer pH 7) 
for 20 h at 37ºC, in the presence of 10 µM pepstatin 
A or without this aspartic-protease inhibitor. The degra-
dation of A1PI was examined using a colorimetric assay 
that monitors a decrease of inhibitory capacity against 
trypsin (Sigma). The reaction was conducted in 100 mM 
Tris-HCl pH 8, at an enzyme : inhibitor molar ratio of 
1:1 at 37°C. Trypsin activity was detected using N-α-
benzoyl-l-arginine 4-nitroanilide hydrochloride (Sigma) 
as the substrate, and determined after 30 min of incuba-
tion by absorbance measurement at 410 nm.
Degradation of A1PI and IL-8 by individual puri-
fied SAPs. Ten SAPs were overproduced in Pichia pasto-
ris GS115 (Invitrogen, USA) as was described previously 
(Aoki et al., 2011). A1PI and IL-8 were incubated with 
all SAPs at an enzyme : substrate molar ratio of 1:20 in 
50 mM citrate buffer, pH 5 and 6, at 37°C for 20 h. 
The reaction was stopped by addition of pepstatin A at 
a final concentration of 10 µM. Products of degradation 
were separated and identified by SDS-PAGE in the Lae-
mmli system (Laemmli, 1970) on a 12% gel, with band 
visualization by silver staining (Blum et al., 1987).
Analysis of the inhibitory properties of native and 
SAP-treated A1PI towards native or NET-associated 
neutrophil elastase. The analysis of inhibitory prop-
erties of native and SAP degraded A1PI (dA1PI) were 
performed in 100 mM Tris-HCl pH 8.0 for 30 min at 
37ºC in a 96-well microtiter plate. Both forms of the 
inhibitor were incubated with native or NET-associated 
neutrophil elastase at an enzyme : inhibitor molar ratio 
of 0:1, 0.25:1, 0.5:1, 1:1, 2:1 and 3:1. The amount of 
NET-associated NE in total pool of isolated NET-asso-
ciated protein was estimated according to data presented 
by Urban et al. (2009). The residual enzyme activity was 
determined using a chromogenic substrate, MeOSuc-Ala-
Ala-Pro-Val-pNA (Sigma). Progress of the reaction was 
measured spectrophotometrically at 410 nm.
Mass spectrometry analysis of A1PI degradation 
products generated by SAP-catalyzed proteolysis. 
The products obtained after degradation of A1PI by 
those SAPs which exhibited the highest hydrolytic activ-
ity toward this inhibitor were analyzed by liquid chro-
matography (LC)-coupled tandem mass spectrometry 
(MS/MS). The low molecular mass degradation prod-
ucts were analyzed directly using the LC-MS/MS system. 
After SDS-PAGE, the bands of the main degradation 
products were in-gel digested with trypsin. Briefly, after 
the visualization of the protein fragments with the colloi-
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dal Coomassie Brilliant Blue dye, the excised pieces were 
washed twice with 50 mM (NH4)HCO3 in 25% and 50% 
acetonitrile (ACN, high-performance liquid chromatogra-
phy (HPLC)-gradient grade, Merck, Darmstadt, Germa-
ny) to remove the dye from the gel. After reduction with 
10 mM dithiotreitol (DTT) for 60 min at 37°C, samples 
were alkylated with 55 mM iodoacetamide for 2 hours 
in the dark and then washed with 100 mM (NH4)HCO3. 
After dehydration with ACN, samples were dried and 
subsequently re-swelled with a digestion buffer, contain-
ing 12.5 ng/μl of the sequencing-grade modified trypsin 
(Promega, Madison, WI, USA), 50 mM (NH4)HCO3 and 
4 mM CaCl2. The gel pieces were incubated overnight at 
37°C. The extractions of acidic and basic peptides were 
conducted by addition of 50 mM (NH4)HCO3 and 5% 
formic acid in 50% ACN, respectively. Combined su-
pernatants were diluted with water and subjected to the 
LC-MS/MS analysis using ultra-high-performance liquid 
chromatography (UHPLC) Dionex Ultimate 3000 sys-
tem (Thermo-Scientific, Woltham, MA, USA) coupled to 
HTCultra ETDII ion-trap mass spectrometer equipped 
with electrospray (ESI) ion source and electron transfer 
dissociation (ETD II) fragmentation module (Bruker, 
Bremen, Germany). The A1PI fragments were separat-
ed on Accucore C-18 column (2.6 μm, 2.1 × 100 mm, 
ThermoScientific) in a binary linear gradient formed be-
tween solvent A (0.1% formic acid (Sigma)) and solvent 
B (0.1% formic acid in 80% ACN), from 10 to 55% of 
B in 38 min, at a flow rate of 0.2 ml/min.
The mass spectrometry measurements were performed 
with the following instrument setup: a positive ion mode, 
capillary voltage of 3.5 kV, the nebulizing gas (nitrogen) 
pressure of 40 psi, drying gas (nitrogen) flow of 12 l/
min and the dry gas temperature of 350°C. Spectra were 
acquired in MS/MS mode in the range of 100–3000 m/z 
with CID (collision-induced dissociation) and ETD ion 
fragmentation, and analyzed using Data AnalysisTM 4.0 
and BiotoolsTM 3.2 software (Bruker, Germany). The 
identification of peptide sequences was performed by 
submission of the data to an in-house Mascot server 
ver. 2.3.0 (Matrix Science, UK) and based on searching 
against Swiss-Prot database.
ELISA method for the detection of the IL-8 bind-
ing by native and degraded A1PI. Native A1PI and its 
degraded forms obtained by treatment with representa-
tive SAPs (dA1PI) were used to detect their binding ca-
pacity to IL-8 (Novoprotein Scientific). The formation 
of the A1PI- and dA1PI-IL-8 complex was analyzed by 
a sandwich ELISA method. The mixtures, containing 
constant amount of IL-8 and native or degraded A1PI at 
a molar ratio of 0.05:1, 0.1:1, 1:1, 2:1 were incubated at 
room temperature for 1 h. The samples were then added 
to 96-well microtiter plates coated with anti-IL-8 anti-
body and incubated for 1.5 h at room temperature. The 
amount of free IL-8 versus A1PI/dA1PI-bound IL-8 was 
determined using HUMAN IL-8 ELISA KIT II (BD 
OptEIA) according to the supplier’s instructions.
Treatment of human cells with NETs and the vi-
ability tests. HMEC-1 and A431 cells were seeded on 
96-well plates (2 × 104 cells/well in 200 µl medium) and 
cultured to 90% of confluency. The cells were washed 
with PBS, and then the NET suspension with total pro-
tein concentrations of 0, 10, 20, 30 μg/ml in the medi-
um were added. After 22 h of incubation at 37°C, the 
wells were washed with PBS. Viability of the cells was 
estimated with the MTT assay (Sigma).
To determine the influence of A1PI or dA1PI inhi-
bition on the activity of NE-accompanying NETs, the 
NET samples (10 μg/ml) were first incubated with A1PI 
or dA1PI for 1 h as above, and then applied to the cells. 
The cells treated with pure medium were used as a con-
trol. Special references for possible influence of SAPs 
used for A1PI treatment at corresponding concentra-
tions were applied instead of NET samples during the 
determination of cell viability.
Treatment of C. albicans with NETs and the 
yeast survival tests. C. albicans cells were harvested at 
the stationary phase by centrifugation at 1500 × g for 10 
min, then were washed twice with PBS and diluted to 
a concentration of 5 × 104 cells/ml in PBS. In order to 
evaluate the impact of NETs on the viability of C. albi-
cans cells, the yeast cell suspensions (200 μl/well) were 
incubated with NETs as described above at 0–30 μg/
ml concentration of NET protein components, and at 
various time intervals. After incubation, the cell viability 
analysis was performed using MTT test, as well as the 
number of viable Candida cells was determined by plat-
ing the serial dilutions of cell suspensions on Sabouraud 
dextrose agar plates. The CFU (colony forming units) 
were counted after 24 h of incubation at 30°C.
Analysis of NET-dependent human cell destruc-
tion effects on C. albicans propagation. To analyze 
the effect of human cell destruction by NETs on C. al-
bicans propagation two models of co-cultures were used.
A one-step co-culture. The human cell monolayers 
covered with C. albicans cells (5 × 104 cells/well of 96-well 
microplate) were treated with NETs (0, 10, 20, 30 μg/
ml) for 2–4 h at 37°C. After incubation, the superna-
tants were removed and the cells were gently washed 
with PBS. Yeasts attached to the human cell monolay-
ers were scraped gently with pipet tips and washed with 
200 μl of distilled water. The resulting suspensions were 
diluted 10-fold, spread on Sabouraud agar plates and 
handled further as described above.
A two-step co-culture. The human cell monolayers 
were first treated with NET samples (0, 10, 20, 30 μg/
ml of protein concentration) for 2–4 h at 37°C. Then 
the supernatant was removed and the stability of mono-
layer was checked by phase contrast microscopy before 
addition of C. albicans cells (5 × 104 cells/well of 96-well 
plate) for the next 2 h of incubation under the same 
conditions. The C. albicans cells attached to the human 
cell monolayer were quantified as described above.
Statistical analysis. The unpaired one-tailed Student’s 
t-test with a Bonferroni correction where necessary was 
used. A p value < 0.05 was considered significant.
RESULTS
Several aspartic proteases of C. albicans efficiently 
degrade A1PI
In order to demonstrate a potential ability of aspartic 
proteases secreted by C. albicans to degrade A1PI at the 
infection foci, A1PI samples were treated with SAP-con-
taining supernatants from C. albicans cultures propagated 
under conditions favoring either yeast-like (YPD supple-
mented with 0.2% BSA) or hyphal (RPMI) morphology 
of the fungus. Influence of the degradation process on 
the inhibitory properties of A1PI towards trypsin was 
tested (Fig. 1A). We found that a more efficient inactiva-
tion of A1PI occurred in the presence of supernatants 
obtained from conditions that favor yeast-like morphol-
ogy, at the pH range from 4 to 6. Using pepstatin A, a 
selective aspartic protease inhibitor, we confirmed SAP 
involvement in the presented A1PI inactivation.
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To select among all SAPs for those enzymes that 
mainly participate in the process, A1PI samples were 
treated with purified individual SAPs at enzyme : sub-
strate ratios of 1:20 for 20 h at 37°C. The retained in-
hibitory capacity of degraded A1PI, analyzed by using 
trypsin as the test enzyme, pointed out to SAP1, SAP2, 
SAP3, SAP4 and SAP9 as proteases leading to the loss 
of A1PI inhibitory properties (Fig. 1B).
The SDS-PAGE analysis (Fig. 2, left panel) correlat-
ed the above enzymatic activity tests with visible cleav-
age of A1PI molecule by the SAP representatives men-
tioned above. At a more acidic pH, SAPs produced by 
both morphological forms of C. albicans were able to 
cleave A1PI. However, at a broader pH range, A1PI 
was cleaved by SAPs that are mainly associated with the 
yeast-like form of C. albicans (SAP1, SAP2, SAP3 and 
SAP9). The last one, SAP9, is also expressed by the hy-
phal form, but is rarely secreted into the medium and 
has a predominant membrane localization (Naglik et al., 
2003). The hyphae-associated SAP4 was comparably ef-
fective in A1PI degradation at pH 5, confirming the re-
sults presented for A1PI treated with the SAP-containing 
supernatants.
To localize the points of SAP-dependent cleavage 
within A1PI molecule, the amino acid sequences of 
the main products were identified by in-gel digestion 
of SDS-PAGE-separated bands with trypsin, followed 
by LC-MS/MS analysis. This analysis revealed that the 
cleavage of A1PI was mainly limited to the hydrolysis of 
K343-G344 bond, resulting in a formation of a stable 
product (dA1PI) with the sequence shortened by 51 ami-
no acid residues in comparison to the native A1PI form 
(Fig. 2, right panel). The shorter peptide was further de-
graded into smaller variants, without any effect on the 
dA1PI properties.
SAP-degraded A1PI changes its inhibitory activity 
towards neutrophil elastase, present in NET structures, 
and looses the ability to bind IL-8
The main target for homeostatic function of A1PI in 
human organism is NE that during microbial infection 
can be spread as the NET constituent at the sites of 
neutrophil contact with microbes. First, we tested if NE 
localized to NET structures during their isolation is still 
active and possibly available for and inhibited by A1PI 
(Fig. 3A). The comparable results of inhibition obtained 
for native and NET-associated NE corroborated such 
model. Moreover, the treatment of NET-embedded NE 
with A1PI degraded by the most potent SAPs (dA1PI) 
led to the partial restoration of NE activity as compared 
to treatment with native A1PI (Fig. 3B).
The intensification of NET production at sites of bac-
terial or fungal infection occurred as a results of the ac-
tion of additional stimuli, such as IL-8 which is produced 
by incoming or surrounding cells. However, the avail-
ability of IL-8 can be modulated by its binding to A1PI. 
On the other hand, a degradation of IL-8 by any SAP 
Figure 1. Changes of A1PI inhibitory properties upon treatment with C. albicans aspartic proteases.
A1PI was degraded (dA1PI) at different pH by cell-free supernatants, containing SAPs produced by C. albicans cells, cultured in YPD or 
RPMI medium (A) or treated by purified SAPs, overexpressed in P. pastoris (B). The reaction was monitored for residual A1PI inhibitory 
capacity against trypsin at an enzyme : inhibitor molar ratio of 1:1, using Nα-benzoyl-l-arginine 4-nitroanilide hydrochloride as substrate. 
The activity of uninhibited trypsin under the same experimental conditions was taken as 100%.
Figure 2. Identification of the cleavage products of A1PI pro-
cessing by Candida aspartic proteases.
Left panel: SDS-PAGE analysis of A1PI degradation products gen-
erated during A1PI contact with individual SAPs at an enzyme : 
substrate molar ratio of 1:20 in 50 mM citrate buffer, pH 5 (A) and 
6 (B) at 37°C for 20 h. A1PI and its degradation product (dA1PI) 
were visualized by silver staining of SDS-PAGE gels. Right panel: 
The mass-spectrometry identification of A1PI degradation prod-
ucts with indication of major cleavage points by NE (black arrow) 
and SAP9 (gray arrows). The sequence underlined represents the 
known cleavage region for bacterial proteases.
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at different incubation time, pH and IL-8:SAP ratio was 
not observed (data not presented). To test the influence 
of A1PI degradation on A1PI ability to form a complex 
with IL-8, we used an ELISA method in which the cy-
tokine unbound to A1PI was detected. The IL-8 binding 
by A1PI that prevents IL8 detection at the experimental 
conditions of ELISA test, was observed (Fig. 4). How-
ever, the degraded A1PI (dA1PI) blocked efficiently the 
complex formation with IL-8, whose molecules were still 
detected in solution during the experiments.
Human cell destruction by NETs can be influenced by 
A1PI and modulated by C. albicans SAPs
A number of studies had shown that an excessive 
production of NETs can lead to cell and tissue destruc-
tion (Saffarzadeh et al., 2012), for which the regulation 
of elastase activity may be crucial. To address this prob-
lem, we chose two types of human cell lines, epithelial 
(A431) and endothelial (HMEC-1), that were treated 
with isolated NETs and, thereafter, the cell viability was 
measured using the MTT test. To eliminate possible side 
Figure 3. Influence of SAP-catalyzed A1PI degradation on its inhibitory properties against elastase, embedded in NET structures.
Inhibition of native (NE) and NET-associated elastase (NE/NET) by A1PI was compared using various enzyme : inhibitor molar ratios (A). 
The residual activity of NE was measured with MeOSuc-Ala-Ala-Pro-Val-pNA as substrate. Effect of A1PI degradation by selected SAPs on 
the inhibitory capacity against NE/NET was carried out under the same conditions using an enzyme : inhibitor molar ratio of 1:1 (B).
Figure 4. IL-8 binding by native (A1PI) and SAP-degraded 
(dA1PI) elastase inhibitor.
Formation of the complexes of A1PI/dA1PI with IL-8 was detected 
using HUMAN IL-8 ELISA Kit II at a constant amount of IL-8 and 
varied A1PI/dA1PI ratio.
Figure 5. NET toxicity against human cells and its changes upon cell treatment with A1PI.
HMEC-1 and A431 cell monolayers were treated with suspension of NETs at different total protein concentrations (0–50 μg/ml) for 22 h. 
The viability of the cells was measured by the MTT assay and relatively expressed to non-treated cells (A). The impact of A1PI and dA1PI 
(degraded by SAP1-S1; SAP3-S3; SAP9-S9) on HMEC-1 cell viability during NET treatment (10 μg/ml) of HMEC-1 cells (B) was determined 
in the same manner. The molar ratio of A1PI/dA1PI used was calculated according to the amount of NE in NETs, estimated as was pro-
posed by Urban et al. (2009). The possible contribution of SAP1, SAP3 and SAP9 to the observed effects was also taken into account 
(marked S1, S3 and S9, respectively).
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effects of destroyed neutrophils on the analyzed cells, 
the NET structures produced during PMA stimulation 
of neutrophils were first detached from the neutrophils 
by MNase treatment that also caused a slight fragmen-
tation of the supporting DNA scaffold. The amount of 
NETs used in further experiments was determined based 
on their protein content. The results presented in the 
Fig. 5A confirmed earlier reports of destructive action 
of NETs on epithelial and endothelial cells, but in our 
models the endothelium seemed to be more susceptible 
to NET presence than epithelial cells.
The observed NET-generated damages to both types 
of cells can result from actions of many factors, consti-
tuting NETs, one of them being elastase. To verify this 
hypothesis the HMEC-1 monolayer was treated with 
NETs as was described above but at a lower protein 
concentration, 10 µg/ml. The NET-dependent damages 
lowered the cell viability to 75%. When the monolayer 
was treated with NETs previously incubated in the pres-
ence of increased concentrations of A1PI, the observed 
changes showed a gradual increase in cell viability, more 
or less comparable with the initial conditions, confirm-
ing that a large part of the destructive forces of NETs 
is constituted by elastase (Fig. 5B) whose action can be 
controlled and even totally blocked in NETs by A1PI. 
On the other hand, when A1PI was treated with SAPs 
known to be most potent in A1PI degradation (SAP1, 
SAP2, SAP9), that produced C-terminally truncated 
A1PI variant (dA1PI) with the concomitant loss of an-
ti-elastase properties, the protective effect disappeared. 
With increasing concentrations of dA1PI the cell viabil-
ity dropped to the initial destructive level. At the same 
time, the SAPs present at the experimental conditions, 
can also influence cell viability but the control results 
performed for pure SAPs showed only a 5–7% contribu-
tion of SAP to this effect.
Human cell destruction by NETs promotes the 
propagation of candidal infection
Neutrophils use several strategies to fight against bac-
terial and fungal infection, including NET formation, but 
many microorganisms developed different mechanisms to 
survive. The destruction of the surrounding tissue may add 
to the fungal survival strategy. To verify this hypothesis, we 
constructed the models of mutual interactions between C. 
Figure 6. Influences of uncontrolled NET generation on the viability of C. albicans cells and the ability to colonize the NET-damaged 
epithelial and endothelial cells.
The yeast-like cells were treated with NET proteins (0–30 μg/ml) for 2–16 h and the fungal viability was determined by CFU measure-
ments, in comparison to non-treated cells (A). The colonization of NET-damaged human cells by C. albicans was assayed in two models: 
sequential (B, C: the human cell treatment with NET, followed by colonization with C. albicans) and simultaneous (D, E: NET impaired 
both human and pathogen cells at the same time).
Vol. 63       173Candida albicans proteases inactivate human α1-proteinase inhibitor
albicans cells and epithelial (A431) or endothelial (HMEC-1) 
cells being in contact with NETs. First, we checked the ef-
fects of isolated NETs on the viability of fungal cells (Fig. 
6A). Measurements performed for a short period of contact 
time (2 h) showed about 60% decrease in fungal cell vi-
ability, but after a longer time of contact (16 h) the fungal 
cells recovered their growth, in comparison to the control 
conditions. Even more, some NET constituents may stimu-
late the fungal growth as the full neutrophil extract does 
(data not shown). Next, we analyzed the possible spreading 
of C. albicans cells over epithelial and endothelial cell mon-
olayer, both influenced by NET treatments during different 
periods of time (2–4 h) at different NET-protein concen-
tration (0–30 µg/ml). For this approach, two models were 
used. In the first model, the human cells were first treated 
with NETs for various time periods, and then NETs were 
removed and human cell monolayers were covered for 2 h 
by C. albicans cells, whose attachment and growth were fur-
ther analyzed by CFU methods. In another model, human 
and pathogen cells were allowed to be influenced by NETs 
at the same time in a mutual contact. The results obtained 
from both models (Fig. 6B–E) clearly indicate that the 
damaged human cells become more susceptible to further 
C. albicans colonization. The longer time of NET treatment 
favored C. albicans colonization. In the light of these results, 
the usage of a variety of SAPs by the fungus for the dereg-
ulation of elastase control due to the SAP-dependent A1PI 
degradation and for possible modulation of chemotaxis 
serves to the superior goal, i.e. further propagation of infec-
tion. However, excessive production of NETs at the fungal 
infection site leads to the destruction of both fighters. Once 
again, the human endothelium seemed to be more sensitive 
for destruction and susceptible to further colonization by 
the fungus.
DISSCUSION
C. albicans is well adapted to changes occurring in its 
environment, i.e. the host tissues and cells. In the adap-
tation processes, C. albicans engages aspartic proteases to 
degrade tissue barriers, to inactivate host defense mol-
ecules, and to digest host proteins for nutrient supply 
(Naglik et al., 2003). However, SAPs also contribute to 
the induction of the inflammatory response of the host 
by stimulation of cytokine expression (Naglik et al., 2003; 
Schaller et al., 2005), acting directly (Pietrella et al., 2010) 
or in an indirect way, through a disruption of the com-
plexes involved in maintaining the host’s homeostasis. 
One of these interactions, important for the biochemical 
homeostasis in the host organism, is the protease-inhib-
itor complex formation between neutrophil elastase and 
its major regulator, A1PI.
Neutrophils, being the first immune cells arriving at the 
site of infection, are able to extracellularly release their gran-
ular proteins or to form NET structures, both resulting in 
a local eruption of neutrophil serine proteases, mainly NE, 
that on one hand can inactivate bacterial or fungal viru-
lence factors (Belaaouaj et al., 1998; Tkalcevic et al., 2000), 
but on the other hand they are also involved in a variety 
of inflammatory conditions, including chronic lung diseases 
(chronic obstructive pulmonary disease, cystic fibrosis, acute 
lung injury, and acute respiratory distress syndrome) (Bergin 
et al., 2012). Moreover, NE induces the production of pro-
inflammatory cytokines in the lungs, thus augmenting the 
inflammation (Meyer-Hoffert & Wiedow, 2011), but also 
inactivates extracellular immune mediators such as immuno-
globulins, complement components, and cathelicidin (Tralau 
et al., 2004; Stromstedt et al., 2009).
Once released, proteolytically active NE is under con-
trol of A1PI that is responsible for maintaining the bal-
ance, being of a critical importance for the protection 
of lung tissues (Greene et al., 2008; Reeves et al., 2010; 
Tuder et al., 2010). Alveolar epithelial cells are known 
to produce A1PI locally which may contribute to both 
the anti-protease defense and anti-inflammatory effects 
within the lung (Venembre et al., 1994). Our work shows 
here for the first time that such a complex between NE 
and A1PI can be also formed when NE is present with-
in the NET structures.
For many bacterial infections, the NE-A1PI balance 
can be disturbed due to the efficient inactivation of 
A1PI by proteases secreted by microorganisms, result-
ing in serious tissue damage (Sires et al., 1994; Sponer 
et al., 1991). As the serpin core possesses a highly or-
dered structure (Elliott et al., 1998), the exposed reactive-
site loop of A1PI is generally the primary target for the 
proteolytic attack of bacterial enzymes (Rapala-Kozik et 
al., 1999). Several bacterial proteases were found to op-
erate in a close vicinity to the NE-cleavage site (M358-
S359) within this loop, i.e., to hydrolyze peptide bonds 
between residues F352 and I360 (Rapala-Kozik et al., 
1999). In the current study we present for the first time 
that similarly, aspartic proteases of a fungal pathogen 
— C. albicans — can also cleave the A1PI reactive loop 
at the K343-G344 bond, impairing the A1PI inhibitory 
properties. In the selection of SAPs that are most effi-
cient in A1PI degradation, acidic conditions were pre-
ferred. They refer to severe bacterial infections, observed 
in cystic fibrosis where characteristic feature of the in-
flammatory sites is a local acidosis, which is attributed 
to the increase of lactic acid production by the anaero-
bic, glycolytic activity of infiltrating neutrophils (Lardner, 
2001; Coakley et al., 2000). Our results showed that the 
most efficient inactivation of A1PI was performed by 
SAP1, SAP2 and SAP3, proteases predominantly pro-
duced by the yeast-like forms, contributing to the patho-
gen dissemination. Hyphae-specific protease SAP4 also 
functions in the acidic environment and can be impor-
tant in A1PI degradation during prolonged infections. 
Additionally, the surface-bound SAP9 which is expressed 
by both morphological forms contributes to A1PI cleav-
age. Thus, independently from the reversible switch be-
tween the unicellular yeast-like form and the elongated 
filamentous form, C. albicans is well equipped with the 
A1PI-degrading power. The action of SAP9 can be of 
a special importance if the fungus is locally arrested in 
NET structures. Our data are consistent with previous 
observations that C. albicans mutants lacking either SAP1 
or SAP2 genes caused a lesser tissue damage in infec-
tion models and had a significantly reduced potential to 
stimulate cytokine expression. In contrast, mutants lack-
ing SAP4 to SAP6 induced similar levels of cytokines to 
those in the wild-type strain (Schaller et al., 2003).
The same data had shown that plasma A1PI binds to 
circulating neutrophils and is localized to the outer sur-
face of the cell membrane which may facilitate the abil-
ity of A1PI to regulate key neutrophil inflammatory re-
sponses including cell chemotaxis (Bergin et al., 2010). By 
forming the complex with IL-8, A1PI inhibits CXCR1 
engagement, with a negative impact on the downstream 
CXCR1 signaling events. Our present results show that 
the degradation of A1PI by fungal proteases affects not 
only the interaction with elastase but also the complex 
formation between A1PI and IL-8. This chemokine 
interacts with glycosylated part of A1PI molecule via 
charge complementation (Bergin et al., 2010; Reeves et 
al., 2010). Although the SAP-truncated A1PI retains all 
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the binding sites for IL-8, the interaction is weaker by 
ca. 50%, as compared to native A1PI molecule. This 
may be related to possible changes in A1PI conforma-
tion that can occur during proteolysis of reactive site 
loop, limiting access to IL-8 binding sites (Knäuper et al., 
1990).
Our results correspond to the findings of Pietrella et 
al. (2010) who demonstrated a strong ability of SAP1, 
SAP2 and SAP6 to induce inflammatory cytokines, and 
are consistent with a low capacity to induce inflamma-
tion found in null mutants lacking either SAP1 or SAP2 
(Schaller et al., 2005). Such uncontrolled local accumula-
tion of IL-8 can be involved in the recruitment of neu-
trophils to the site of infection and is observed under 
conditions of persistent neutrophilic airway inflamma-
tion (Hartl et al., 2007). For example, during the initial 
stages of acute lung injury and acute respiratory distress 
syndrome, a massive accumulation of neutrophils in the 
vasculature of the lung was also identified (Cheng et al., 
2013).
The migration of neutrophils to sites of infection is 
beneficial for the host because of their ability to kill 
pathogens. However, the presence of neutrophils at the 
infection foci may also be deleterious when an exces-
sive, uncontrolled amount of NE is released into the 
extracellular medium, leading to lung matrix degradation. 
Pathologic effects of NE are also associated with micro-
vascular injury, causing endothelial damage and increased 
capillary permeability that may enhance the transloca-
tion of microorganisms across the endothelial cell barrier 
and initiate bacteremia (Moraes et al., 2003). In epithelial 
and endothelial cell models, used in the present study, 
we also found that NET-associated NE partially influ-
ences the viability of both cell types. The effect is most 
pronounced when NE activity is no longer controlled 
by SAP-truncated A1PI. But at the same moment, a de-
struction of pathogen also occurred. Such effects raise a 
question if the local imbalance in the host protein home-
ostasis is really cost-effective for C. albicans cells, where 
parts of the population could be killed during deregula-
tion of the host homeostasis. However, our models of 
NET-dependent impairment of epithelial and endothelial 
cells clearly indicated that the cells presented a surface 
more accessible for C. albicans colonization. Even the 
partial destruction of C. albicans cells in this situation 
cannot influence the total population of pathogen cells. 
Although the observation on a short time scale demon-
strated drastic fungal killing effects, very often shown 
in published reports, during longer time of coloniza-
tion, the remaining and still alive fungal cells can restore 
the whole population or even stimulate its growth by a 
yet unidentified stimulator, liberated during neutrophil 
breakdown, as was also noted by Urban et al. (2006).
Moreover, C. albicans is often associated with the pol-
ymicrobial community that is more resistant to any treat-
ment, as it was shown in pneumonia and cystic fibrosis, 
where C. albicans interacts with typical pneumonia path-
ogens, such as Pseudomonas aeruginosa (Mear et al., 2013; 
Ader et al., 2011). It is probable that in such situations, 
especially in pulmonary fungal infections which have 
been systematically studied in recent years (Chotirmall & 
MacElvaney, 2014; Roux et al., 2013; Wahab et al., 2014), 
the deregulation of well-balanced homeostatic protein-
protein complexes of the host is more profitable for 
maintaining the pathogen community.
Taken together, the results obtained in the present 
study reveal that C. albicans SAPs are able to disturb 
A1PI-NE complex formation, thus influencing epithelial 
and endothelial cell colonization and adding another pro-
cess of cytokine enhancement to the virulence attributes 
of this fungal pathogen.
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